Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Silvestre Vicent|Nature Communications|2023Cited by 23
Anticancer Activity of RAS-GTP Inhibition in CholangiocarcinomaRodrigo Entrialgo‐Cadierno, Yingyun Wang, Jim Evans et al.|Cancer Cell|2025Cited by 0